ST CHARLES, Mo.--(BUSINESS WIRE)--D2 Pharma Consulting LLC (D2) is best-in-class consulting firm, exclusively focusing on pharma services in the life sciences industry. D2 assists emerging and established pharmaceutical and biopharmaceutical companies to develop and execute strategic business initiatives, ensuring successful launch, distribution and ongoing leadership position in the marketplace.
Dean Erhardt, MBA, and Dan Steiber, R.Ph. are the Principals and founding partners of D2. The evolution of D2 is a strategic progression of expanding the pharma and biotech services both principals and key D2 members have been providing to the pharmaceutical industry. Joining D2 are over twelve (12) other highly experienced associates with over 200 years of combined healthcare services experience.
D2 Pharma Consulting services include:
* Strategic Decision and Project Management * Commercial Launch Development * Supply Chain Management * Trade and National Accounts Support * Specialty Distribution and Pharmacy Network Establishment * New Product Launch Planning * Third Party Logistic Provider Selection and Implementation * Marketing and Pull Thru Support
Dean Erhardt stated: “We are excited about the synergies of combing the unique core competencies of a broad team that expands the business model, bringing greater overall value to current and future clients.” Previously, Mr. Erhardt was principal of his own consulting firm, servicing the needs of multiple pharmaceutical clients and life sciences associations. Dean was a senior executive with Express Scripts specialty group and has extensive management experience with Cardinal Health and US Healthcare.
Mr. Dan Steiber, a pharmacist, has held several senior executive positions with two industry firms including a leading drug wholesaler and retail drug chain, Longs Drug Stores, later serving as General Manager of third-party logistics firm. “With the number of challenges surrounding product entry into the US pharmaceutical market, D2 focuses on real world solutions and getting it done. Our industry leadership, expertise and innovative methodologies make us a strong partner to our clients,” stated Mr. Steiber.
Any further questions should be forwarded to Dean Erhardt at dean.erhardt@d2rx.com, (314) 308-2028 or Dan Steiber at dan.steiber@d2rx.com, (972) 795-3082. Information is also available at www.d2rx.com or info@d2rx.com.
Contact:
D2 Pharma Consulting LLC Dean Erhardt, 314-308-2028 dean.erhardt@d2rx.com or Dan Steiber, 972-795-3082 dan.steiber@d2rx.com
